Strides Pharma Science informs about press release

05 Feb 2026 Evaluate

Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge, New York Inspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain’.

The above information is a part of company’s filings submitted to BSE. 

Strides Pharma Scien Share Price

856.00 -3.75 (-0.44%)
06-Feb-2026 12:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1695.50
Dr. Reddys Lab 1227.75
Cipla 1325.00
Zydus Lifesciences 887.40
Lupin 2181.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×